Outcome Category

Mixed

at Supreme Court of India

6 mixed decisions from Supreme Court of India.

Mixed Decisions

6 cases | Page 1 of 1

patent mixed · Jan 22, 2026

Gloster Limited (SRA) v.Gloster Cables Limited & Ors.

Supreme Court of India · Civil Appeal No. 2996 of 2024

The Supreme Court addressed a complex dispute regarding the ownership and status of the trademark 'Gloster' within the context of insolvency proceedings (IBC). The core issue was whether the trademark, which had been assigned to Gloster Cables Limited (GCL), remained an asset of the Corporate Debtor. The Court ultimately set aside the Adjudicating Authority’s finding that the trademark belonged to the Corporate Debtor, but clarified that this ruling did not definitively resolve the underlying title dispute between the parties. This judgment highlights the limitations of insolvency forums in adjudicating complex intellectual property ownership claims.

patent mixed · Jan 8, 2019

Monsanto Technology Llc Thru The Authorised Representative Ms. Natalia Voruz & Others v.Nuziveedu Seeds Ltd. Thru The Director & Others

Supreme Court of India · Civil Appeal Nos. 4616-4617 of 2018

This Supreme Court judgment addressed a dispute between Monsanto Technology LLC and Nuziveedu Seeds Ltd. concerning the use of patented Bt cotton technology ('BOLGARD'). The core issue revolved around whether the defendants' rights were protected under the PPVFR Act, potentially invalidating the patent claims, or if the plaintiffs could enforce their registered patent for infringement. The court ultimately restored a Single Judge's interim injunction and remanded the suit, emphasizing that complex questions of patent validity must be decided after full evidence is adduced during trial.

patent mixed · Apr 1, 2013

Novartis Ag v.Union Of India & Ors

Supreme Court of India · Civil Appeal Nos. 2706-2716 of 2013 (Arising out of SLP(C) Nos. 20539-20549 of 2009)

This landmark Supreme Court judgment addressed the critical interplay between Section 3(d) of the Patents Act, 1970, and the definition of 'invention.' The case centered on Novartis's claim for a patent covering the beta crystalline form of Imatinib Mesylate (marketed as Glivec/Gleevec), a life-saving drug. The Court was tasked with balancing the need to encourage pharmaceutical research and development against India’s commitment to ensuring affordable access to essential medicines, particularly in developing nations.

patent mixed · Sep 16, 2009

Bajaj Auto Ltd v.TVS Motor Company Ltd

Supreme Court of India · Civil Appeal No. 6309 of 2009

This Supreme Court judgment addressed the protracted nature of patent infringement litigation, specifically concerning Bajaj Auto Ltd versus TVS Motor Company Ltd. The court emphasized that matters relating to patents must be decided expeditiously by the Trial Court rather than remaining stuck at the interlocutory stage over temporary injunctions. Consequently, the appeal was disposed of with directions mandating the respondent to file a written statement and directing the appointment of a Receiver to monitor sales records until the suit is finally disposed of.

patent mixed · Nov 7, 2005

Bhavanesh Mohanlal Amin And Anr. v.Nirma Chemicals Works And Anr.

Supreme Court of India · Appeal (civil) 6622 of 2005

The Supreme Court reviewed an appeal challenging a temporary injunction restraining the appellants from using the mark 'NIMA'. While initially vacating the interim relief, the SC ultimately modified the order, directing that the respondents could not initiate any action for use of 'NIMA' by the appellants without leave of the trial court until the suit is disposed of. The Court also directed the lower court to expedite the hearing and disposal of the long-pending trademark infringement case.

trademark mixed · May 7, 2004

Milmet Oftho Industries & Ors. v.Allergan Inc.

Supreme Court of India · Appeal (civil) 5791 of 1998

The Supreme Court addressed a passing off dispute concerning the pharmaceutical mark 'OCUFLOX' between an Indian company and a multinational corporation. While acknowledging the global nature of medicine and the potential harm from confusion, the court emphasized that the ultimate test remains who was first in the market. The judgment directed the trial court to continue the injunction while expediting the suit for final determination based on evidence regarding prior use.

Arctic Invent — IP Strategy

Facing a similar IP matter?

Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.

Consult our team →